<DOC>
	<DOC>NCT00801398</DOC>
	<brief_summary>When post-operative parenteral analgesia is discontinued, oral dosing with study medication may begin once the subject has developed a moderate level of pain as defined by a 100 mm VAS (pain intensity score greater than or equal to 40).</brief_summary>
	<brief_title>Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Oxymorphone</mesh_term>
	<criteria>Male or female &gt; 12 to 17 years of age, inclusive Weigh at least 50 kg Postoperative oral opioid analgesia required for at least 24 hours or 48 hours following postoperataive parenteral analgesia Are expected to be hospitalized for the duration of the study Known allergy to, or a significant reaction to, oxymorphone or another opioid Life expectancy of &lt; 4 weeks Positive pregnancy test at screening</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Opioid tolerant</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Pain</keyword>
	<keyword>Non malignant</keyword>
	<keyword>Malignant</keyword>
</DOC>